JETEMA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79260875
Serial Number
79260875
Registration Number
6071731
Word Mark
JETEMA
Status
700 - Registered
Status Date
2020-06-09
Filing Date
2019-05-03
Registration Number
6071731
Registration Date
2020-06-09
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2020-03-24
Attorney Name
Law Office Assigned Location Code
M60
Employee Name
EINSTEIN, MATTHEW T
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Translation of Words in Mark
The wording "JETEMA" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-06-20
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kisuk Lee
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1472050
International Registration Date
2019-05-03
International Publication Date
2019-06-13
International Renewal Date
2029-05-03
Auto Protection Date
2020-12-13
International Status
001 - Request for extension of protection established
International Status Date
2019-06-13
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-06-13SN ASSIGNED FOR SECT 66A APPL FROM IB
2019-06-20NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-06-25APPLICATION FILING RECEIPT MAILED
2019-07-11ASSIGNED TO EXAMINER
2019-07-11NON-FINAL ACTION WRITTEN
2019-07-12NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2019-07-15NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
2019-07-15NON-FINAL ACTION WRITTEN
2019-07-16NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2019-08-01REFUSAL PROCESSED BY MPU
2019-08-02NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2019-08-23REFUSAL PROCESSED BY IB
2020-01-29TEAS VOLUNTARY AMENDMENT RECEIVED
2020-01-29TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-29CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-30TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-19APPROVED FOR PUB - PRINCIPAL REGISTER
2020-03-04NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-03-24PUBLISHED FOR OPPOSITION
2020-03-24OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-06-09REGISTERED-PRINCIPAL REGISTER
2020-09-09FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2020-09-29FINAL DISPOSITION PROCESSED
2020-09-29FINAL DISPOSITION NOTICE SENT TO IB
2020-10-17FINAL DECISION TRANSACTION PROCESSED BY IB